Utilidad de la monitorización terapéutica de vedolizumab en el control de la respuesta en enfermedad de Crohn
Medicina Clínica · 2026
DOI: 10.1016/j.medcli.2025.107254 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medicina Clínica, 2026. Verfasst von Laura Moñino-Dominguez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Virgen Macarena, Sevilla, España. Electronic address: ezlaura@gmail.com. Hauptthemen laut MEDLINE: Crohn Disease, Antibodies, Monoclonal, Humanized, Drug Monitoring, Gastrointestinal Agents. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The predictive value of therapeutic drug monitoring (TDM) of vedolizumab in Crohn's disease (CD) during the maintenance phase remains uncertain. This study assessed its association with clinical and biochemical remission in routine clinical practice and explored variables influencing trough concentration variability. METHODS: A retrospective observational study was conducted at a tertiary hospital between July 2022 and December 2024. Adult CD patients receiving vedolizumab during maintenance and undergoing routine TDM were included. Clinical variables (age, treatment duration, administration route, perianal disease), laboratory markers (albumin, C-reactive protein [CRP], fecal calprotectin [FCP]), and pharmacokinetic data were collected. Trough concentrations were measured using ELISA. Clinical remission was defined as a Harvey-Bradshaw Index
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Universitario Virgen Macarena, Sevilla, España. Electronic address: ezlaura@gmail.com.
- Hospital Universitario Virgen Macarena, Sevilla, España.
Zitieren
APA
Moñino-Dominguez, L., Aguado-Paredes, A., Cordero-Ramos, J., Tirado-Pérez, M. J., Martínez-Escudero, A., Argüelles-Arias, F., & Merino-Bohórquez, V. (2026). Utilidad de la monitorización terapéutica de vedolizumab en el control de la respuesta en enfermedad de Crohn. Medicina Clínica. https://doi.org/10.1016/j.medcli.2025.107254
Vancouver
Moñino-Dominguez L, Aguado-Paredes A, Cordero-Ramos J, Tirado-Pérez MJ, Martínez-Escudero A, Argüelles-Arias F, et al. Utilidad de la monitorización terapéutica de vedolizumab en el control de la respuesta en enfermedad de Crohn. Medicina Clínica. 2026. doi:10.1016/j.medcli.2025.107254
BibTeX
@article{MoinoDominguez2026,
author = {Moñino-Dominguez, Laura and Aguado-Paredes, Alicia and Cordero-Ramos, Jaime and Tirado-Pérez, Maria José and Martínez-Escudero, Alejandro and Argüelles-Arias, Federico and Merino-Bohórquez, Vicente},
title = {Utilidad de la monitorización terapéutica de vedolizumab en el control de la respuesta en enfermedad de Crohn},
journal = {Medicina Clínica},
year = {2026},
doi = {10.1016/j.medcli.2025.107254}
}
EUVIMED